Skip to main content

Peer Review reports

From: The insoluble excretion of multi-matrix system mesalazine preparations in patients with ulcerative colitis

Original Submission
14 Apr 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
18 May 2022 Reviewed Reviewer Report
21 May 2022 Reviewed Reviewer Report
26 May 2022 Reviewed Reviewer Report
28 May 2022 Reviewed Reviewer Report - Sakuma Takahashi
8 Jul 2022 Author responded Author comments - Yuichiro Ohtaki
Resubmission - Version 4
8 Jul 2022 Submitted Manuscript version 4
9 Jul 2022 Author responded Author comments - Yuichiro Ohtaki
Resubmission - Version 5
9 Jul 2022 Submitted Manuscript version 5
18 Jul 2022 Author responded Author comments - Yuichiro Ohtaki
Resubmission - Version 6
18 Jul 2022 Submitted Manuscript version 6
25 Jul 2022 Reviewed Reviewer Report
2 Aug 2022 Reviewed Reviewer Report - Sakuma Takahashi
4 Aug 2022 Author responded Author comments - Yuichiro Ohtaki
Resubmission - Version 7
4 Aug 2022 Submitted Manuscript version 7
10 Aug 2022 Reviewed Reviewer Report - Sakuma Takahashi
Resubmission - Version 8
Submitted Manuscript version 8
Publishing
11 Aug 2022 Editorially accepted
18 Aug 2022 Article published 10.1186/s12876-022-02474-9

You can find further information about peer review here.

Back to article page